Institutional Ownership Tarsus Pharmaceuticals, Inc. (TARS)
This table provides information about the institutional ownership of Tarsus Pharmaceuticals, Inc. (TARS). We have compiled data on the 170 institutions that hold shares in the stock, with a total of 43.3 Million shares, which have been reported (via 13F filing form) to have a value of $2.02 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Rothschild Investment LLC
Chicago, IL |
Oct 18, 2024 Q3 2024 |
40
shares
|
$1,793
0.0% of portfolio
|
Q3 2024
Added 300.0%
|
|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
39
shares
|
$1,748
0.0% of portfolio
|
Q3 2022
New holding
|
|
Sterling Capital Management LLC
Charlotte, NC |
Nov 12, 2024 Q3 2024 |
38
shares
|
$1,703
0.0% of portfolio
|
Q3 2024
New holding
|
|
Global Retirement Partners, LLC
|
Oct 16, 2024 Q3 2024 |
38
shares
|
$1,703
0.0% of portfolio
|
Q3 2024
New holding
|
|
Gamma Investing LLC
Foster City, CA |
Oct 04, 2024 Q3 2024 |
36
shares
|
$1,613
0.0% of portfolio
|
Q3 2024
Reduced 74.29%
|
|
Smartleaf Asset Management LLC
Boston, MA |
Nov 13, 2024 Q3 2024 |
27
shares
|
$1,210
0.0% of portfolio
|
Q3 2024
New holding
|
|
Cwm, LLC
|
Oct 08, 2024 Q3 2024 |
27
shares
|
$1,210
0.0% of portfolio
|
Q3 2024
Reduced 27.03%
|
|
Farther Finance Advisors, LLC
San Francisco, CA |
Oct 28, 2024 Q3 2024 |
12
shares
|
$537
0.0% of portfolio
|
Q4 2023
New holding
|
|
Quadrant Capital Group LLC
Cincinnati, OH |
Nov 12, 2024 Q3 2024 |
6
shares
|
$268
0.0% of portfolio
|
Q3 2024
New holding
|
|
Capital Performance Advisors LLP
|
Nov 01, 2024 Q3 2024 |
5
shares
|
$224
0.0% of portfolio
|
Q3 2024
New holding
|
|
Covestor LTD
Boston, MA |
Nov 01, 2024 Q3 2024 |
3
shares
|
$134
0.0% of portfolio
|
Q1 2024
New holding
|
|
Huntington National Bank
Columbus, OH |
Nov 06, 2024 Q3 2024 |
1
shares
|
$44
0.0% of portfolio
|
Q1 2024
Reduced 99.93%
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|